A detailed history of Kerber Rose Wealth Management, LLC transactions in Bristol Myers Squibb CO stock. As of the latest transaction made, Kerber Rose Wealth Management, LLC holds 2,893 shares of BMY stock, worth $114,736. This represents 0.18% of its overall portfolio holdings.

Number of Shares
2,893
Holding current value
$114,736
% of portfolio
0.18%

Shares

1 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Aug 11, 2022

BUY
$72.62 - $79.98 $210,089 - $231,382
2,893 New
2,893 $223,000

Others Institutions Holding BMY

About BRISTOL MYERS SQUIBB CO


  • Ticker BMY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,126,160,000
  • Market Cap $84.3B
  • Description
  • Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...
More about BMY
Track This Portfolio

Track Kerber Rose Wealth Management, LLC Portfolio

Follow Kerber Rose Wealth Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Kerber Rose Wealth Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Kerber Rose Wealth Management, LLC with notifications on news.